Patrice Rioux - 01 Jan 2025 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MNPR	Stock Options	Award	$0	+2,000		$0.000000	2,000	01 Jan 2025	Common Stock	2,000	$22.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Stock Options vesting commenced on January 1, 2025 as follows: 1/12th of 2,000 options on January 31, 2025 and each subsequent month-end thereafter.